Search

Your search keyword '"Santiago, Aguadé-Bruix"' showing total 190 results

Search Constraints

Start Over You searched for: Author "Santiago, Aguadé-Bruix" Remove constraint Author: "Santiago, Aguadé-Bruix"
190 results on '"Santiago, Aguadé-Bruix"'

Search Results

1. Vall d’Hebron Risk Score II for myocardial infarction and cardiac death

3. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

4. 1H NMR serum metabolomic profiling of patients at risk of cardiovascular diseases performing stress test

6. Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study

7. Planning the Follow-Up of Patients with Stable Chronic Coronary Artery Disease

8. Prediction of a major adverse coronary event in Women through CORSWO

9. Insights into insulin resistance and calcification in the Myocardium in type 2 dDiabetes: a coronary artery analysis

10. Selección de lo mejor del año 2020 en imagen cardiovascular

11. International Impact of COVID-19 on the Diagnosis of Heart Disease

12. Mosaic Bioprostheses May Mimic Infective Endocarditis by PET/CTA

13. Coste-efectividad de la SPECT de perfusión miocárdica y de la prueba de esfuerzo en relación con la revascularización coronaria, eventos cardíacos y mortalidad total. Registro de 8.496 pacientes

14. Cost-effectiveness of myocardial perfusion SPECT and stress test according to coronary revascularization therapy, cardiac events and total mortality: Register of 8496 patients

15. Usefulness of the Vall d'Hebron Risk Score to stratify the risk of patients with ischemic cardiomyopathy

16. Long-term intense FDG uptake in a non-infected prosthetic aortic heart valve implanted 18 years ago

17. Impact of revascularization guided by functional testing in ischaemic cardiomyopathy

18. Phenotyping Type 2 Diabetes in Terms of Myocardial Insulin Resistance and Its Potential Cardiovascular Consequences: A New Strategy Based on

19. The valve uptake index: a new measure in [18F]FDG PET/CT for the diagnosis of prosthetic valve endocarditis

20. Equilibrium radionuclide angiography: Present and future

21. The valve uptake index: improving assessment of prosthetic valve endocarditis and updating [18F]FDG PET/CT(A) imaging criteria

22. Reduction of cardiac imaging tests during the COVID-19 pandemic: The case of Italy. Findings from the IAEA Non-invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

23. Identification of Myocardial Insulin Resistance by Using Liver Tests: A Simple Approach for Clinical Practice

24. Q waves in ischemic cardiomyopathy

25. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

26. Clinical significance of Q waves in ischemic cardiomyopathy

27. Prognostic benefit of nonemergent revascularization on ischaemic dilated cardiomyopathy depending on patient symptoms

28. Impact of COVID-19 on Diagnostic Cardiac Procedural Volume in Oceania: The IAEA Non-Invasive Cardiology Protocol Survey on COVID-19 (INCAPS COVID)

29. Recurrent superinfection in a patient with transjugular intrahepatic portosystemic shunt (endotipsitis), findings on 18F-FDG PET/CT

31. Correction to: Morpho-metabolic post-surgical patterns of non-infected prosthetic heart valves by [18F]FDG PET/CTA: 'normality' is a possible diagnosis

32. 18 F-FDG-PET/CT angiography in the diagnosis of infective endocarditis and cardiac device infection in adult patients with congenital heart disease and prosthetic material

33. Gender differences in outcome in patients with diabetes mellitus

34. Mosaic Bioprostheses May Mimic Infective Endocarditis by PET/CTA: Trust the Uptake Pattern to Avoid Misdiagnosis

35. Morpho-metabolic post-surgical patterns of non-infected prosthetic heart valves by [18F]FDG PET/CTA: 'normality' is a possible diagnosis

36. 194Initial assessment of the clinical impact and confirmation of the diagnostic ability of the 18F-FDG-PET/CTA prosthetic valve endocarditis

37. P317How attenuation correction affects the interpretation of 123I-mIBG SPECT images of cardiac sympathetic innervation

38. A novel clinical risk prediction model for myocardial infarction, coronary revascularization, and cardiac death according to clinical, exercise, and gated SPECT variables (VH-RS)

39. Diagnostic performance of the quantification of myocardium at risk from MPI SPECT/CTA 2G fusion for detecting obstructive coronary disease: A multicenter trial

40. 18 F-FDG-PET/CTA of Prosthetic Cardiac Valves and Valve-Tube Grafts

41. Right-sided endocarditis on Contegra tube in a complex cianotic congenital heart disease

42. Perspective and future direction of intraventricular mechanical dyssynchrony assessment

43. P2274First assessment of the clinical impact and confirmation of the diagnostic ability of the 18F-FDG-PET/CTA prosthetic valve endocarditis. New data supports initial results

44. 524918F-FDG-PET/CTA of prosthetic cardiac valves: postsurgical inflammatory patterns and its temporal evolution. Can we question the 3-month limit of the current guidelines?

45. Selección de temas de actualidad en imagen cardiaca 2015

46. Cardiac Imaging 2015: A Selection of Topical Issues

47. Improving the Diagnosis of Infective Endocarditis in Prosthetic Valves and Intracardiac Devices With 18 F-Fluordeoxyglucose Positron Emission Tomography/Computed Tomography Angiography

49. SPECT, angio-TC coronaria, coronariografía invasiva e imágenes de fusión en la cardiopatía isquémica estable

50. Obtención de una fórmula que mejora la estimación del consumo máximo de oxígeno en las pruebas de esfuerzo con bicicleta ergométrica

Catalog

Books, media, physical & digital resources